RAPP
RAPP
US75383L1026
Rapport Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
125.099.000 83.055.000
50.6%
Operating Income -125.099.000 -83.055.000
50.6%
Pretax Income -111.483.000 -78.307.000
42.4%
Net Income Common Stockholders -111.483.000 -78.307.000
42.4%
-- --
--
-- --
--
ende